These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 22633963

  • 1. N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze.
    John CS, Currie PJ.
    Behav Brain Res; 2012 Aug 01; 233(2):382-8. PubMed ID: 22633963
    [Abstract] [Full Text] [Related]

  • 2. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Micale V, Cristino L, Tamburella A, Petrosino S, Leggio GM, Drago F, Di Marzo V.
    Neuropsychopharmacology; 2009 Feb 01; 34(3):593-606. PubMed ID: 18580871
    [Abstract] [Full Text] [Related]

  • 3. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats.
    Lee J, Di Marzo V, Brotchie JM.
    Neuropharmacology; 2006 Sep 01; 51(3):557-65. PubMed ID: 16806299
    [Abstract] [Full Text] [Related]

  • 4. The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice.
    Costa B, Bettoni I, Petrosino S, Comelli F, Giagnoni G, Di Marzo V.
    Pharmacol Res; 2010 Jun 01; 61(6):537-46. PubMed ID: 20138997
    [Abstract] [Full Text] [Related]

  • 5. Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats.
    Pardo-García TR, Yusif-Rodriguez N, Yudowski G, Maldonado-Vlaar CS.
    Neurosci Lett; 2020 Jul 27; 732():135023. PubMed ID: 32422166
    [Abstract] [Full Text] [Related]

  • 6. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
    Maione S, De Petrocellis L, de Novellis V, Moriello AS, Petrosino S, Palazzo E, Rossi FS, Woodward DF, Di Marzo V.
    Br J Pharmacol; 2007 Mar 27; 150(6):766-81. PubMed ID: 17279090
    [Abstract] [Full Text] [Related]

  • 7. Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei.
    Moreira CM, Masson S, Carvalho MC, Brandão ML.
    Brain Res Bull; 2007 Mar 15; 71(5):466-74. PubMed ID: 17259015
    [Abstract] [Full Text] [Related]

  • 8. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus.
    Gobira PH, Lima IV, Batista LA, de Oliveira AC, Resstel LB, Wotjak CT, Aguiar DC, Moreira FA.
    J Psychopharmacol; 2017 Jun 15; 31(6):750-756. PubMed ID: 28583049
    [Abstract] [Full Text] [Related]

  • 9. The cannabinoid receptor CB₁ inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala.
    Dono LM, Currie PJ.
    Neuropharmacology; 2012 Jan 15; 62(1):192-9. PubMed ID: 21736884
    [Abstract] [Full Text] [Related]

  • 10. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM, Canto-de-Souza A.
    Brain Res; 2008 Sep 22; 1231():93-102. PubMed ID: 18621039
    [Abstract] [Full Text] [Related]

  • 11. The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats.
    de Novellis V, Vita D, Gatta L, Luongo L, Bellini G, De Chiaro M, Marabese I, Siniscalco D, Boccella S, Piscitelli F, Di Marzo V, Palazzo E, Rossi F, Maione S.
    Mol Pain; 2011 Jan 17; 7():7. PubMed ID: 21241462
    [Abstract] [Full Text] [Related]

  • 12. GABA and histamine interaction in the basolateral amygdala of rats in the plus-maze test of anxiety-like behaviors.
    Hajizadeh Moghaddam A, Roohbakhsh A, Rostami P, Heidary-Davishani A, Zarrindast MR.
    Pharmacology; 2008 Jan 17; 82(1):59-66. PubMed ID: 18477857
    [Abstract] [Full Text] [Related]

  • 13. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats.
    Kokare DM, Dandekar MP, Chopde CT, Subhedar N.
    Brain Res; 2005 May 10; 1043(1-2):107-14. PubMed ID: 15862523
    [Abstract] [Full Text] [Related]

  • 14. The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats.
    de Novellis V, Palazzo E, Rossi F, De Petrocellis L, Petrosino S, Guida F, Luongo L, Migliozzi A, Cristino L, Marabese I, Starowicz K, Di Marzo V, Maione S, Endocannabinoid Research Group.
    Neuropharmacology; 2008 Dec 10; 55(7):1105-13. PubMed ID: 18616956
    [Abstract] [Full Text] [Related]

  • 15. Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice.
    Chegini HR, Nasehi M, Zarrindast MR.
    Behav Brain Res; 2014 Mar 15; 261():114-26. PubMed ID: 24333573
    [Abstract] [Full Text] [Related]

  • 16. Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system.
    Zarrindast MR, Sroushi A, Bananej M, Vousooghi N, Hamidkhaniha S.
    Eur J Pharmacol; 2011 Dec 15; 672(1-3):106-12. PubMed ID: 21968140
    [Abstract] [Full Text] [Related]

  • 17. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
    Millns PJ, Chimenti M, Ali N, Ryland E, de Lago E, Fernandez-Ruiz J, Chapman V, Kendall DA.
    Eur J Neurosci; 2006 Dec 15; 24(12):3489-95. PubMed ID: 17229097
    [Abstract] [Full Text] [Related]

  • 18. Involvement of CB1 and TRPV1 receptors located in the ventral medial prefrontal cortex in the modulation of stress coping behavior.
    Sartim AG, Moreira FA, Joca SRL.
    Neuroscience; 2017 Jan 06; 340():126-134. PubMed ID: 27771531
    [Abstract] [Full Text] [Related]

  • 19. The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus.
    Bambico FR, Duranti A, Nobrega JN, Gobbi G.
    Eur Neuropsychopharmacol; 2016 Mar 06; 26(3):578-90. PubMed ID: 26747370
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.